Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹555 Cr.
Stock P/E
23.6
P/B
3.1
Current Price
₹227.1
Book Value
₹ 72.7
Face Value
10
52W High
₹358
52W Low
₹ 185.4
Dividend Yield
0%

Chandan Healthcare Overview

Business

Chandan Healthcare Ltd. is an Indian company operating in the Hospital & Healthcare Services sector. Its core business involves providing comprehensive medical care, diagnostics, and related health services through its network of hospitals and healthcare facilities. The company primarily generates revenue by charging patients for medical consultations, diagnostic tests, in-patient treatments, surgeries, pharmacy services, and other specialized healthcare procedures. It aims to cater to the healthcare needs of the population, focusing on delivering accessible and quality medical services.

Revenue Mix

While specific revenue contributions are not provided, Chandan Healthcare's operations typically encompass:

Hospital Services: Includes out-patient consultations, in-patient admissions, surgeries, emergency services, and specialty clinics across various medical disciplines.

Diagnostic Services: Covers a range of pathological tests, radiology (X-rays, CT scans, MRIs), and other imaging services.

Pharmacy Services: Sale of medicines and medical supplies to patients within its facilities.

Other services may include preventative health check-ups and corporate health programs.

Industry

The Indian hospital and healthcare services industry is characterized by robust growth, driven by a large and aging population, rising incidence of chronic diseases, increasing health awareness, and growing insurance penetration. The industry is fragmented, with a mix of large corporate chains, mid-sized regional players, single-specialty hospitals, and numerous small clinics. Chandan Healthcare, identified by its ticker CHANDAN, likely positions itself as a regional or multi-city player, aiming to provide quality care at accessible price points, competing with both larger established corporate hospitals and local independent healthcare providers in its operational geographies.

MOAT

Chandan Healthcare's potential competitive advantages could stem from:

Local Brand Reputation: If established in specific regions, a strong local brand name and patient trust built over time can be a significant advantage.

Doctor Relationships: Ability to attract and retain skilled medical professionals and specialists, who often bring patient loyalty.

Operational Efficiency: Managing costs effectively to offer competitive pricing while maintaining service quality.

Service Mix & Accessibility: Providing a comprehensive range of services, including diagnostics, under one roof, or having a well-located network of facilities.

Growth Drivers

Rising Healthcare Expenditure: Increasing disposable incomes and greater willingness to spend on quality healthcare.

Demographic Shifts: A growing and aging population leading to higher demand for medical services, especially for chronic and lifestyle diseases.

Expansion of Facilities: Opening new hospitals, diagnostic centers, or specialized clinics in underserved or high-growth areas.

Medical Tourism: Potential to attract patients from neighboring regions or countries, depending on specialization and service quality.

Health Insurance Penetration: Increased coverage makes healthcare more affordable and accessible, driving demand.

Technological Advancements: Adoption of new medical technologies and procedures can attract more patients and improve treatment outcomes.

Risks

Regulatory & Pricing Pressure: Government interventions in healthcare pricing, quality standards, and licensing can impact profitability.

Intense Competition: Highly competitive landscape from established players, new entrants, and single-specialty clinics.

Talent Attrition: Difficulty in attracting and retaining highly skilled doctors, nurses, and other medical staff.

Capital Intensive Business: High capital expenditure required for setting up and upgrading facilities, equipment, and technology.

Medical Malpractice & Litigation: Risks associated with patient care, leading to potential lawsuits and reputational damage.

Economic Slowdown: Healthcare, though essential, can see reduced discretionary spending on elective procedures during economic downturns.

Management & Ownership

As a company with "Chandan" in its name, it is likely promoted and significantly owned by its founders or the Chandan family, common among Indian enterprises. Promoter groups typically hold a substantial stake, providing stable ownership and long-term vision. Management quality would generally be focused on navigating the complexities of the Indian healthcare sector, including operational efficiency, expansion strategies, talent acquisition, and adherence to medical standards. Other ownership would include institutional investors and public shareholders.

Outlook

Chandan Healthcare operates in a sector with strong secular tailwinds in India, driven by increasing demand for healthcare services. The company has opportunities for growth through geographical expansion, service diversification, and leveraging its brand within its operational regions. However, it faces significant challenges including intense competition, the capital-intensive nature of the hospital business, and potential regulatory interventions on pricing. Success will hinge on its ability to execute expansion plans efficiently, attract and retain medical talent, maintain high standards of patient care, and manage costs effectively in a competitive and evolving market.

Chandan Healthcare Share Price

Live · NSE · Inception: 2003
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Chandan Healthcare Quarterly Results

#(Fig in Cr.) Dec 2024 Mar 2025 Jun 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 55 63 68 65 76 81
Other Income 0 2 1 1 2 1
Total Income 55 65 69 66 77 82
Total Expenditure 46 52 54 53 63 61
Operating Profit 9 13 15 13 14 21
Interest 1 1 1 1 2 5
Depreciation 1 3 4 2 2 4
Exceptional Income / Expenses 0 0 0 -2 -1 0
Profit Before Tax 7 9 10 7 9 12
Provision for Tax 2 3 3 2 2 4
Profit After Tax 5 6 6 5 7 8
Adjustments -0 -0 -0 -0 -0 -0
Profit After Adjustments 4 6 6 5 7 7
Adjusted Earnings Per Share 2.1 2.5 2.4 1.9 2.8 3.1

Chandan Healthcare Profit & Loss

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 120 137 177 230 290
Other Income 0 0 1 2 5
Total Income 120 137 178 232 294
Total Expenditure 117 128 150 189 231
Operating Profit 3 10 28 43 63
Interest 2 2 3 5 9
Depreciation 2 2 3 7 12
Exceptional Income / Expenses 0 0 0 0 -3
Profit Before Tax -1 5 21 32 38
Provision for Tax 0 1 5 9 11
Profit After Tax -1 4 16 24 26
Adjustments -2 -0 -0 -1 0
Profit After Adjustments -3 3 16 22 25
Adjusted Earnings Per Share -1.6 1.7 8.1 9.1 10.2

Chandan Healthcare Balance Sheet

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 24 27 41 123
Minority's Interest 3 3 2 4
Borrowings 7 8 12 22
Other Non-Current Liabilities 3 4 4 5
Total Current Liabilities 45 57 58 57
Total Liabilities 82 98 118 211
Fixed Assets 29 33 48 76
Other Non-Current Assets 9 12 8 24
Total Current Assets 43 54 61 110
Total Assets 82 98 118 211

Chandan Healthcare Cash Flow

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 3 2 2 4
Cash Flow from Operating Activities 6 4 1 -29
Cash Flow from Investing Activities -11 -6 -15 -36
Cash Flow from Financing Activities 3 2 16 67
Net Cash Inflow / Outflow -1 0 2 2
Closing Cash & Cash Equivalent 2 2 4 6

Chandan Healthcare Ratios

# Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) -1.59 1.68 8.14 9.07
CEPS(Rs) 0.43 2.84 9.88 12.38
DPS(Rs) 0.5 1 1.5 0
Book NAV/Share(Rs) 11.97 13.65 20.58 50.14
Core EBITDA Margin(%) 1.89 6.85 14.95 17.96
EBIT Margin(%) 0.54 5.43 13.71 15.92
Pre Tax Margin(%) -0.89 3.66 12.15 13.93
PAT Margin (%) -0.91 2.62 9.26 10.22
Cash Profit Margin (%) 0.73 4.15 11.19 13.15
ROA(%) -1.34 3.99 15.13 14.31
ROE(%) -4.57 14 47.78 28.72
ROCE(%) 1.59 16.67 38.52 29.57
Receivable days 87.61 69.84 54.05 59.72
Inventory Days 20.03 21.91 29.06 39.35
Payable days 184.62 220.93 142.42 89.69
PER(x) 0 0 0 19.96
Price/Book(x) 0 0 0 3.61
Dividend Yield(%) 0 0 0 0
EV/Net Sales(x) 0.29 0.29 0.29 2.11
EV/Core EBITDA(x) 13.43 4.13 1.88 11.17
Net Sales Growth(%) 0 14.49 29 30.31
EBIT Growth(%) 0 1050.2 225.87 51.32
PAT Growth(%) 0 428.27 356.06 43.77
EPS Growth(%) 0 206.07 383.27 11.41
Debt/Equity(x) 0.69 0.78 0.87 0.39
Current Ratio(x) 0.96 0.95 1.06 1.94
Quick Ratio(x) 0.81 0.77 0.75 1.39
Interest Cover(x) 0.38 3.07 8.8 8.01
Total Debt/Mcap(x) 0 0 0 0.11

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +30% +24% — —
Operating Profit CAGR +54% +143% — —
PAT CAGR +50% — — —
Share Price CAGR -1% — — —
ROE Average +29% +30% +21% +21%
ROCE Average +30% +28% +22% +22%

Chandan Healthcare Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 49.61 %
FII 0.01 %
DII (MF + Insurance) 5.09 %
Public (retail) 45.29 %
# Mar 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 49.4349.4749.4749.5549.61
FII 3.861.1100.010.01
DII 6.75.024.765.035.09
Public 4044.4145.7845.4245.29
Others 00000
Total 100100100100100

Chandan Healthcare Peer Comparison

Hospital & Healthcare Services Edit Columns

Chandan Healthcare Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Chandan Healthcare Pros & Cons

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 30%
  • Debtor days have improved from 142.42 to 89.69days.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 49.61%.
  • Stock is trading at 3.1 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp